# A Study of PTS for Patients With Solid Tumors

> **NCT03448211** · PHASE1 · WITHDRAWN · sponsor: **PTS International Inc.**

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Para-toluenesulfonamide Injection (PTS)

## Key facts

- **NCT ID:** NCT03448211
- **Lead sponsor:** PTS International Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-01
- **Primary completion:** 2019-05-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Development strategy reasons
- **Last updated:** 2018-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448211, "A Study of PTS for Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03448211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*